Construction Begins on the
“Kashiwa-no-ha Hotel Project (tentative name)”
to Create a New Clinical Model in Kashiwa-no-ha
- Scheduled to Open a Hospital-Linked Accommodation Facility in Summer 2022
to Support Cancer Treatment and Research -

December 22, 2020
Mitsui Fudosan Co., Ltd.
Mitsui Fudosan Hotel Management Co., Ltd.
National Cancer Center Japan

Tokyo, JAPAN – December 22, 2020 – Mitsui Fudosan Co., Ltd., a leading global real estate company headquartered in Tokyo, and National Cancer Center Japan (Headquarters: Chuo-ku, Tokyo; President: Hitoshi Nakagama;“NCC”) announced today the start of construction of the“Kashiwa-no-ha Hotel Project (tentative name)” on December 16 on the grounds of the National Cancer Center Hospital East (Location: 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan; Director: Atsushi Ohtsu,“NCC Hospital East”).

With this project, Mitsui Fudosan will lease a part of the grounds of NCC Hospital East and construct a hotel (total number of guest rooms planned: 146) on the site. After completion, Mitsui Fudosan Hotel Management Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President and CEO, Masaru Sasabe;“Mitsui Fudosan Hotel Management”) will operate the hotel, to open in summer 2022.

Illustration of the completed building *Subject to change

The development is on the premises of NCC Hospital East, six minutes by bus from Kashiwanoha-campus Station on the Tsukuba Express Line. NCC Hospital East, one of the leading specialized cancer hospitals in Japan, treats nearly 300,000 cancer patients a year from both Japan and overseas. There are cases where patients must undergo regular outpatient treatment for a certain period of time, or where patients must travel from afar to undergo inpatient or outpatient treatment. In order to meet these and other needs of visitors and improve convenience, NCC and Mitsui Fudosan have decided to construct this accommodation facility adjacent to the hospital on the NCC Hospital East grounds.

Mitsui Fudosan and NCC are working closely together, exploring specific services, functions and features that will support cancer patients and their family members, beginning with designs for guest rooms and public areas. The development of new healthcare services such as telemedicine, sensing devices, and other technologies are planned supported by deploying communications infrastructure such as 5G and IT. Through these initiatives, Mitsui Fudosan and NCC will create a new clinical model in collaboration with the hospital.

* Mitsui Fudosan and NCC has published the following news release dated June 22, 2020 in connection with this project.  News release for reference:“National Cancer Center Japan and Mitsui Fudosan Agree on Accommodation Facility at the National Cancer Center Hospital East in Kashiwa-no-ha Smart City” (URL)

< Project Overview >

Location 6-5-2, Kashiwa-no-ha, Kashiwa City, Chiba Prefecture
Site Area (Area of block) 11,914.00 m2 (approx. 128,000 ft2) (Including hotel site area of 3,972.43 m2 (approx. 43,000 ft2)
Structure Steel structure, 7 stories above ground
Total Floor Area 8,329.89 m2 (approx. 90,000 ft2)
Guestrooms 146 rooms (planned)
Design and construction Tokyu Construction co., ltd.
Opening Summer 2022 (planned)

< Planned construction site >


Front lobby (image)

Guestroom (suite with kitchen) (image)

■Ground-breaking Ceremony

On Tuesday, December 15, a ground-breaking ceremony was held at the planned construction site. The ceremony was attended by Yoshikazu Kitahara, Managing Director and Executive Vice President; Kazunori Yamashita, General Manager, Kashiwa-no-ha Urban Planning and Development Department, and others from Mitsui Fudosan, along with Hitoshi Nakagama, President, and Atsushi Ohtsu, Director, NCC Hospital East from NCC,.

Yoshikazu Kitahara
Managing Director and Executive Vice President, Mitsui Fudosan Co., Ltd.

Hitoshi Nakagama (center) and Atsushi Ohtsu (left) at the ceremony

■Mitsui Fudosan Co., Ltd.

([Website] Kashiwa-no-ha Smart City)
Mitsui Fudosan is a comprehensive developer that creates new value by striving to resolve social issues through urban development. At Kashiwa-no-ha Smart City, Mitsui Fudosan aims to create a smart, compact city driven by data through the introduction of new technologies such as AI and IoT. It has been selected by the Ministry of Land, Infrastructure, Transport and Tourism as an advanced model project for a smart city towards realizing“Society 5.0.” Going forward, Mitsui Fudosan will work on developing smart medical institution services for health and medicine. In addition, the Mitsui Fudosan Group believes that it can contribute significantly to the realization of Society 5.0, which is advocated by the Japanese government, and to the achievement of the SDGs, by promoting ESG management, which means advancing businesses based on an awareness of the Environment (E), Society (S), and Governance (G).

■ Mitsui Fudosan Hotel Managemen
Mitsui Fudosan Hotel Management currently operates 8,774 guest rooms in 33 hotels under its upper-middle class lodging-focused hotel brand Mitsui Garden Hotels, 504 guest rooms in 3 hotels under its high-class lodging-focused hotel brand THE CELESTINE HOTELS, and 567 guest rooms in 3 hotels under its next-generation new hotel brand“sequence,” with a total of 9,845 guest rooms in 39 hotels. Guided by its philosophy and concept of creating“hotels to remember” and“hotels that satisfy the senses of even the most discerning guests,” Mitsui Fudosan Hotel Management will continue to provide services with abundant hospitality.

■National Cancer Center Hospital East (NCC Hospital East)
The National Cancer Center Hospital East (NCC Hospital East) was established in 1992. It is a leading specialized cancer hospital in Japan, treating over 9,000 new patients each year. NCC Hospital East is designated by the national government as a core hospital for clinical research and a core hospital for cancer genomic treatment, among others. Together with its adjoining facility, the Exploratory Oncology Research & Clinical Trial Center (NCC-EPOC), NCC Hospital East has produced many achievements as a research and development center with its strong international network. NCC Hospital East has been promoting the development of innovative cancer medicines and medical devices and cutting-edge personalized treatment, including genomic medicine.